Deakin University
Browse

File(s) not publicly available

Selective serotonin reuptake inhibitors in mixed anxiety-depression.

journal contribution
posted on 2000-08-01, 00:00 authored by Michael BerkMichael Berk
The overlap between the depressive and anxiety disorders is extremely common. The introduction of the selective serotonin reuptake inhibitors (SSRIs) has, more than any other development, bridged the gap in terms of efficacy in both sets of disorders. A substantial body of data exists suggesting that the available SSRIs have substantial efficacy in anxiety symptoms co-occurring with depression. The clear utility of the SSRIs in disorders classified apart from depression is also established. Whilst panic disorder is the best studied, evidence on the efficacy of the SSRIs in disorders that previously did not attract much pharmacotherapeutic interest, such as social anxiety disorder and post-traumatic stress disorder is accumulating.

History

Journal

International Clinical Psychopharmacology

Volume

15 Suppl 2

Pagination

S41-S45

Location

ENGLAND

ISSN

0268-1315

eISSN

1473-5857

Language

eng

Publication classification

C2.1 Other contribution to refereed journal

Copyright notice

2000, Lippincott, Williams & Wilkins

Issue

SUPPL. 2

Publisher

Lippincott, Williams & Wilkins